Adhesion molecules and developmental epilepsy disorders
粘附分子与发育性癫痫病
基本信息
- 批准号:10592736
- 负责人:
- 金额:$ 54.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinity ChromatographyAnimal ModelBindingBiologicalBiological AssayBiologyBrainCalciumCell Adhesion MoleculesCerebrospinal FluidChildClinicalCortical DysplasiaDataDendritic SpinesDevelopmentDiseaseElectroencephalographyEnzyme-Linked Immunosorbent AssayEpilepsyEtiologyExtracellular DomainFamilyFundingFutureGenesGeneticGrantHippocampus (Brain)HumanImageInheritedInjectionsIntellectual functioning disabilityInterventionLanguage DisordersMapsMass Spectrum AnalysisMembrane ProteinsMethodologyMolecularMolecular NeurobiologyMusMutationNeurodevelopmental DisorderNeuronsOligopeptidesParacrine CommunicationPartial EpilepsiesPathogenesisPathogenicityPatientsPeptidesPharmacologyPhenotypePitt-Hopkins syndromePropertyProteomicsPumpRecombinantsRegulationResearch Project GrantsRoleSamplingSeizuresSeveritiesSliceSpecificitySyndromeTertiary Protein StructureTestingTherapeuticWestern BlottingWild Type Mouseautism spectrum disorderbasebrain abnormalitiescomorbiditycontactindravet syndromegenetic associationhuman subjectimprovedin vivo imaginginsightlanguage impairmentmouse modelmulti-photonneurotransmissionnovelnovel therapeutic interventionpre-clinical
项目摘要
PROJECT SUMMARY
This is a renewal application for a grant aimed to understand abnormal brain development and function in
neurodevelopmental disorders co-morbid with epilepsy, and to explore preclinical rescue strategies with the potential
of to reverse these abnormalities. Neurodevelopmental disorders, such as intellectual disability and autism are often
comorbid with seizure disorders, such as epilepsy. Mutations in a number of genes have recently been discovered
which cause neurodevelopmental disorders comorbid with epilepsy, suggesting common etiological mechanisms.
Among these, genes encoding neuronal adhesion molecules are very highly represented. Here we propose to
continue to investigate novel neuronal functions of a prominent representative of this family, CNTNAP2, mutations in
which cause monogenic syndromes of intellectual disability, autism, and language disorder, comorbid with epilepsy.
Specifically, we will investigate the neurodevelopmental functions of CNTNAP2 ectodomain shedding (cleavage and
release of the extracellular domain) in paracrine signaling. Based on our findings from the previous funding period,
we hypothesize that specific regions on CNTNAP2's ectodomain can modulate network properties and seizure
activity in the intact mouse brain; CNTNAP2-ecto shedding is dysregulated in human subjects with and mouse models
of neurodevelopmental seizure disorders. We will test this hypothesis by combining expertise in molecular
neurobiology, epilepsy, proteomics, and pharmacology, using animal models and human clinical CSF samples, and
by employing several cutting-edge methodologies, in the following Specific Aims: 1) To map the structural
determinants of CNTNAP2-ecto function. 2) To characterize the impact of CNTNAP2-ecto on network and seizure
activity in mice. 3) To explore the relationship between shed ectodomains detected in the CSF and seizure activity.
On a basic level, data generated will provide new insights into the biology of paracrine signaling by neuronal
ectodomain shedding and reveal novel mechanisms of regulation neuronal network activity during brain development.
In the long run, our studies will provide novel insight into the molecular basis of alterations in both epilepsy and
neurodevelopmental disorders and have the potential to provide preclinical proof-of-principle for novel therapeutic
strategies for interventions in developmental seizure disorders.
项目总结
这是一项旨在了解脑部异常发育和功能的基金的续期申请。
神经发育障碍与癫痫共病的临床前抢救策略探讨
来扭转这些反常现象。神经发育障碍,如智力残疾和自闭症,通常
与癫痫等癫痫发作障碍并存。最近发现了许多基因的突变。
这会导致神经发育障碍并伴有癫痫,这表明了常见的病因机制。
其中,编码神经元黏附分子的基因具有很高的代表性。在此,我们建议
继续研究这个家族的一个重要代表CNTNAP2突变的新神经元功能
这会导致智力残疾、自闭症和语言障碍等单基因综合征,并与癫痫并存。
具体地说,我们将研究CNTNAP2胞外结构域脱落(裂解和
细胞外域的释放)旁分泌信号。根据我们在前一个资助期的调查结果,
我们假设CNTNAP2的S胞外区上的特定区域可以调节网络特性和癫痫发作
在完整的小鼠脑中的活动;CNTNAP2-ecto的脱落在人类和小鼠模型中是失调的
神经发育性癫痫。我们将结合分子方面的专业知识来检验这一假说。
神经生物学、癫痫、蛋白质组学和药理学,使用动物模型和人类临床脑脊液样本,以及
通过采用几种尖端方法,在以下具体目标中:1)绘制结构图
CNTNAP2-ecto功能的决定因素。2)表征CNTNAP2-ecto对网络和癫痫发作的影响
小鼠的活动。3)探讨脑脊液中脱落胞外区与癫痫发作活动的关系。
在基础水平上,产生的数据将为神经元旁分泌信号的生物学提供新的见解
胞外区的脱落,揭示了大脑发育过程中调节神经元网络活动的新机制。
从长远来看,我们的研究将为癫痫和癫痫的分子基础提供新的见解。
神经发育障碍,有可能为新的治疗方法提供临床前的原则证据
发育性癫痫障碍的干预策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Penzes其他文献
Peter Penzes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Penzes', 18)}}的其他基金
Neuronal excitability and copy number variation disorders
神经元兴奋性和拷贝数变异障碍
- 批准号:
10039790 - 财政年份:2020
- 资助金额:
$ 54.49万 - 项目类别:
Neuronal excitability and copy number variation disorders
神经元兴奋性和拷贝数变异障碍
- 批准号:
10250497 - 财政年份:2020
- 资助金额:
$ 54.49万 - 项目类别:
Neuronal excitability and copy number variation disorders
神经元兴奋性和拷贝数变异障碍
- 批准号:
10407640 - 财政年份:2020
- 资助金额:
$ 54.49万 - 项目类别:
Neuronal excitability and copy number variation disorders
神经元兴奋性和拷贝数变异障碍
- 批准号:
10626765 - 财政年份:2020
- 资助金额:
$ 54.49万 - 项目类别:
Molecular mechanisms of abnormal dendritic spine plasticity in schizophrenia
精神分裂症树突棘可塑性异常的分子机制
- 批准号:
8287503 - 财政年份:2012
- 资助金额:
$ 54.49万 - 项目类别:
Synaptic and dendritic dysfunction in psychiatric disorders
精神疾病中的突触和树突功能障碍
- 批准号:
9402750 - 财政年份:2012
- 资助金额:
$ 54.49万 - 项目类别:
Molecular mechanisms of abnormal dendritic spine plasticity in schizophrenia
精神分裂症树突棘可塑性异常的分子机制
- 批准号:
8605620 - 财政年份:2012
- 资助金额:
$ 54.49万 - 项目类别:
Molecular mechanisms of abnormal dendritic spine plasticity in schizophrenia
精神分裂症树突棘可塑性异常的分子机制
- 批准号:
8431757 - 财政年份:2012
- 资助金额:
$ 54.49万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 54.49万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 54.49万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 54.49万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 54.49万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 54.49万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 54.49万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 54.49万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 54.49万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 54.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 54.49万 - 项目类别:
Collaborative Research and Development Grants